Schedule

3:00p 5:00p ARRIVAL AND REGISTRATION
5:00p 8:00p WELCOME RECEPTION, COCKTAIL MIXER, APPETIZERS, ENTERTAINMENT, AND PRESENTATIONS
08:00a 09:00a REGISTRATION AND CONTINENTAL BREAKFAST
09:00a 09:15a WELCOME AND INTRODUCTION
09:15a 09:45a OPENING SESSION KEYNOTE ADDRESS
WHAT IS ARTHROFIBROSIS, WHAT ARE THE CAUSES, AND HOW IS IT TREATED?
10:45a 11:15a SCREENING FOR ARTHROFIBROSIS AFTER ANTERIOR CRUCIATE LIGAMENT RE-CONSTRUCTION: ANALYSIS OF ASSOCIATION WITH HUMAN LEUKOCYTE ANTIGEN.
11:15a 11:45a POTENTIAL ARTHROFIBROSIS CANCER TGF-B1 LINK
11:45a 12:15p HEPATITIS AND ARTHROFIBROSIS
SPECIAL LUNCHEON SPEAKER
12:15p 12:45p WHEN DRUG RESEARCH IS PERSONAL: THE IMPORTANCE OF PATIENT ADVOCACY IN DRUG DEVELOPMENT AND INNOVATION
12:45p 01:00p BREAK
01:00p 01:30p OCCUPATIONAL AND ENVIRONMENTAL CAUSES OF ARTHROFIBROSIS
01:30p 02:15p ROUNDTABLES: QUESTIONS AND ANSWERS WITH THE EXPERTS
02:15p 02:30p CLOSING REMARKS
Special Guest Speaker
02:30p 06:30p PATIENT DOCTOR MEET + GREET
06:30p 10:00p NETWORKING COCKTAILS, DINNER, AND ENTERTAINMENT
08:00a 09:00a REGISTRATION AND CONTINENTAL BREAKFAST
09:00a 09:15a WELCOME INTRODUCTION
09:15a 09:45a RESEARCH, THERAPIES, AND THE DRUG PIPELINE
09:45a 10:15a MENISCUS TRANSPLANTATION: INDICATIONS, TECHNIQUES, CLINICAL OUTCOMES.
10:15a 10:45a VISIT EXHIBITS
10:45a 11:15a THE FINAL STAGES OF ARTHROFIBROSIS
11:15a 11:45a TOOLS FOR LIVING BETTER WITH ARTHROFIBROSIS
11:45a 12:00p EFFECTIVE ADVOCACY FOR ARTHROFIBROSIS
12:00p 01:00p LUNCH
01:00p 01:15p THE ROLE OF THE US FDA IN THE PROCESS OF DRUG DEVELOPMENT
01:15p 01:30p US FOOD AND DRUG ADMINISTRATION — PATIENT-FOCUSED DRUG DEVELOPMENT PROGRAM
01:30p 02:30p ROUNDTABLES: QUESTIONS AND ANSWERS WITH THE EXPERTS
02:30p 02:40p CLOSING REMARKS
02:40p 06:00p VISIT EXHIBITS
06:30p 10:00p NETWORKING COCKTAILS, DINNER, AND ENTERTAINMENT
09:00a 05:00p VISIT EXHIBITS
IRRADIATION IN THE TREATMENT OF ARTHROFIBROSIS AFTER TOTAL KNEE ARTHROPLASTY: A PRELIMINARY TRIAL

Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft.

Arthrofibrosis of the knee following ligament surgery.

Knee Surgery: Complications, Pitfalls, and Salvage.

Prevention of arthrofibrosis by monoclonal antibody against vascular endothelial growth factor.